What is the prevalence of Human Papillomavirus (HPV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Prevalence in the United States

Human papillomavirus (HPV) is extremely common, with an estimated 80% of sexually active women acquiring genital HPV by age 50 years. 1 This high prevalence makes HPV the most common sexually transmitted infection in the United States.

Overall Prevalence Data

  • In the United States, approximately 26.8% of females aged 14-59 years have detectable HPV infection at any given time 2
  • Highest prevalence is among women aged 20-24 years (44.8%) 2
  • An estimated 6.2 million new HPV infections occur annually among persons aged 14-44 years 1
  • Of these new infections, 74% occur among those aged 15-24 years 1

Age-Specific Prevalence

HPV prevalence varies significantly by age:

  • Ages 14-19 years: 24.5% 2
  • Ages 20-24 years: 44.8% (peak prevalence) 2
  • Ages 25-29 years: 27.4% 2
  • Ages 30-39 years: 27.5% 2
  • Ages 40-49 years: 25.2% 2
  • Ages 50-59 years: 19.6% 2

There is a statistically significant trend of increasing HPV prevalence with each year of age from 14 to 24 years, followed by a gradual decline through age 59 2.

Cumulative Risk of Infection

  • Modeling estimates suggest that >80% of sexually active women will acquire genital HPV by age 50 1
  • In a prospective study of college women, the cumulative probability of incident infection was 38.9% by 24 months after first sexual intercourse 1
  • HPV acquisition occurs rapidly after sexual debut, with HPV 16 being the most commonly acquired type (10.4%) 1

Prevalence of Specific HPV Types

  • Overall prevalence of vaccine-preventable types (6,11,16, and 18) is 3.4% 2
    • HPV-6: 1.3%
    • HPV-11: 0.1%
    • HPV-16: 1.5%
    • HPV-18: 0.8%

Risk Factors for HPV Infection

The most consistent predictors of HPV infection are:

  • Number of sexual partners (lifetime and recent) 1
    • 14.3% prevalence among women aged 18-25 with one lifetime partner
    • 22.3% prevalence with two lifetime partners
    • 31.5% prevalence with more than three lifetime partners
  • Early onset of sexual activity 1, 3
  • Partner sexual behavior 1
  • Immune status 1
  • Other risk factors include tobacco use, marijuana use, and alcohol use 3

HPV in Men

  • HPV infection is also common among men 1
  • Among heterosexual men in clinic-based studies, prevalence of genital HPV infection often exceeds 20% 1
  • Prevalence is highly dependent on anatomic sites sampled and method of specimen collection 1

Public Health Implications

The high prevalence of HPV has significant public health implications:

  • HPV is a necessary cause of cervical cancer and precursor lesions 1
  • HPV types 16 and 18 account for approximately 68% of squamous cell cancers and 83% of adenocarcinomas 1
  • Prevention strategies include HPV vaccination, consistent condom use (which can reduce HPV infection by approximately 70%), limiting sexual partners, and regular screening 3

The extremely high prevalence of HPV underscores the importance of vaccination before sexual debut and regular screening according to age-appropriate guidelines to reduce the burden of HPV-related diseases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cervical Cancer Screening and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.